%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2018-04-04T09:33:03+02:00
2018-04-04T09:33:07+02:00
2018-04-04T09:33:07+02:00
Adobe InDesign CC 13.1 (Macintosh)
uuid:36b05472-c769-7f4f-b9bd-005c33f13c56
xmp.did:8c48ce2f-27bf-4a29-9bde-a8ffcf92000b
xmp.id:3b7f4a35-c99a-47e0-b330-a95fd732d745
proof:pdf
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 13.1 (Macintosh)
/
2018-04-04T09:33:03+02:00
xmp.iid:88948517-10a1-4a45-aaea-a497b47421b2
xmp.did:8c48ce2f-27bf-4a29-9bde-a8ffcf92000b
xmp.did:8c48ce2f-27bf-4a29-9bde-a8ffcf92000b
default
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
3 0 obj
<>
endobj
5 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/Shading<>/XObject<>>>/TrimBox[0.0 0.0 850.394 850.394]/Type/Page>>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Shading<>/XObject<>>>/TrimBox[0.0 0.0 850.394 850.394]/Type/Page>>
endobj
22 0 obj
<>stream
0 0 0 0 k
/GS0 gs
0 0 850.394 822.047 re
f
q
0 0 850.394 822.047 re
W n
q
0 g
/GS1 gs
0 TL/Fm0 Do
Q
Q
q
0 813.543 396.85 5.669 re
W n
q
0 g
396.8504028 0 0 -396.8504028 0 813.5432739 cm
BX /Sh0 sh EX Q
Q
q
425.197 813.543 396.85 5.669 re
W n
q
0 g
396.8504028 0 0 -396.8504028 425.1968384 813.5432739 cm
BX /Sh0 sh EX Q
Q
BT
0.9 0.6 0.1 0 k
/TT0 1 Tf
10 0 0 10 28.3465 820.0867 Tm
(4)Tj
5.83 0 0 5.83 34.3564 823.4167 Tm
(a)Tj
-0.01 Tc 10 0 0 10 37.5395 820.0867 Tm
( Edizione)Tj
/Span<>> BDC
( )Tj
EMC
19.976 0 Td
(Glaucoma a Brain Disease: )Tj
0 0.9 0.85 0.3 k
0.01 Tw (2018)Tj
0.9 0.6 0.1 0 k
0 Tc 0 Tw 15.905 0 Td
( )Tj
5.72 0 Td
(4)Tj
5.83 0 0 5.83 459.5532 823.4167 Tm
(a)Tj
-0.01 Tc 10 0 0 10 462.7364 820.0867 Tm
( Edizione)Tj
/Span<>> BDC
( )Tj
EMC
19.976 0 Td
(Glaucoma a Brain Disease: )Tj
0 0.9 0.85 0.3 k
0.01 Tw (2018)Tj
0.9 0.6 0.1 0 k
0 Tc 0 Tw 15.905 0 Td
( )Tj
ET
0 0.9 0.85 0.3 K
0.7 w
q 1 0 0 1 153.0081 795.7924 cm
0 0 m
119.181 0 l
S
Q
q 1 0 0 1 151.0551 508.7566 cm
0 0 m
123.087 0 l
S
Q
BT
0 0.9 0.85 0.3 k
-0.02 Tc 14 0 0 14 153.0081 797.1923 Tm
(Gioved\354 12 Aprile)Tj
-0.03 Tc 0.03 Tw 8 0 0 10 28.3464 776.6897 Tm
(15.00)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1381 776.6897 Tm
( )Tj
EMC
1.69 0 Td
(Accredito partecipanti)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3464 766.4384 Tm
(15.20)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1381 766.4384 Tm
( )Tj
EMC
1.69 0 Td
(Apertura Congresso - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 161.7916 766.4384 Tm
[(G. Maira, G. Manni, S. Miglior)91.8 (, L. Rossetti, M. Stirpe)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3464 756.1871 Tm
(15.30)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1381 756.1871 Tm
( )Tj
EMC
/T1_2 1 Tf
-0.02 Tc 0.027 Tw 9.12 0 0 9.6 65.1968 756.1871 Tm
(Lettura Magistrale:)Tj
/T1_0 1 Tf
0.024 Tw 9.5 0 0 10 152.6803 756.1871 Tm
[( Epidemiological burden of blindness and visual disability)-20 ( )]TJ
0 Tc 0 Tw -9.209 -1.025 Td
(in glaucomatous patients - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 185.551 745.9359 Tm
(R. Bourne)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3464 725.4333 Tm
(16.00)Tj
0 0 0 1 k
/GS2 gs
/T1_2 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.12 0 0 9.6 49.1381 725.4333 Tm
( )Tj
EMC
1.761 0 Td
[(DALLA MOR)17.8 (TE CELLULARE ALLA QUALIT\300 DI VIT)73.9 (A)]TJ
/T1_1 1 Tf
/Span<>> BDC
-4.041 -1.068 Td
( )Tj
EMC
0.9 0.6 0.1 0 k
/GS0 gs
/T1_3 1 Tf
4.041 0 Td
(Moderatori: )Tj
0 0 0 1 k
/GS2 gs
/T1_1 1 Tf
[(S. Gandolfi, A. Lambiase, S. Miglior)91.8 (, G. Scuderi)]TJ
/T1_0 1 Tf
-0.02 Tc /Span<>> BDC
9.5 0 0 10 28.3464 694.6794 Tm
( )Tj
EMC
3.879 0 Td
(Patologie Neurodegenerative e meccanismi di morte cellulare - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 334.8042 694.6794 Tm
(M. Matteoli)Tj
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3464 684.4282 Tm
( )Tj
EMC
3.879 0 Td
(Glaucoma: a Neurodegenerative Disease - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 245.0111 684.4282 Tm
[(F)128.9 (.J. Goni)]TJ
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 674.1769 Tm
( )Tj
EMC
3.879 0 Td
(Altre patologie oftalmiche Neurodegenerative - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 271.1262 674.1769 Tm
(S. Bianchi Marzoli)Tj
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 663.9257 Tm
( )Tj
EMC
3.879 0 Td
[(V)17.8 (isual \037eld damage in Glaucoma - )]TJ
/T1_1 1 Tf
9.12 0 0 9.6 212.9127 663.9257 Tm
[(D.F)128.9 (. Garway-Heath)]TJ
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 653.6743 Tm
( )Tj
EMC
3.879 0 Td
(A new approach to perimetry - Eyecatcher - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 252.3352 653.6743 Tm
(D. Crabb)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 633.1718 Tm
(17.30)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 1.412 Tw /Span<>> BDC
9.5 0 0 10 49.1382 633.1718 Tm
( )Tj
EMC
(Discussione)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 612.6693 Tm
(17.45)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1382 612.6693 Tm
( )Tj
EMC
1.69 0 Td
[(Cof)17.8 (fee Break)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 592.1667 Tm
(18.00)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1382 592.1667 Tm
( )Tj
EMC
1.69 0 Td
[(Casi Clinici sulla stabilizzazione del Campo V)17.8 (isivo)]TJ
/T1_1 1 Tf
/Span<>> BDC
9.12 0 0 9.6 28.3465 581.9154 Tm
( )Tj
EMC
0.9 0.6 0.1 0 k
/GS0 gs
/T1_3 1 Tf
4.041 0 Td
(Moderatori)Tj
-0.01 Tc 0.01 Tw (: )Tj
0 0 0 1 k
/GS2 gs
/T1_1 1 Tf
0 Tw 5.87 0 Td
[(M. Iester)91.8 (, A. Perdicchi, L. Rossetti)]TJ
0 Tc /Span<>> BDC
-9.911 -1.068 Td
( )Tj
EMC
0.9 0.6 0.1 0 k
/GS0 gs
/T1_3 1 Tf
-0.01 Tc 0.01 Tw 4.041 0 Td
(Relatori: )Tj
0 0 0 1 k
/GS2 gs
/T1_1 1 Tf
0 Tw 4.124 0 Td
(M. Figus, M. Michelessi, M. Sacchi)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 551.1616 Tm
(18.30)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 1.412 Tw /Span<>> BDC
9.5 0 0 10 49.1382 551.1616 Tm
( )Tj
EMC
(Discussione)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 530.6591 Tm
(19.00)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1382 530.6591 Tm
( )Tj
EMC
/T1_4 1 Tf
1.69 0 Td
(Chiusura prima giornata - Cocktail)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 520.4077 Tm
(20.30)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1382 520.4077 Tm
( )Tj
EMC
1.69 0 Td
(Cena di Gala)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.02 Tc 14 0 0 14 151.0551 510.1565 Tm
(Venerd\354 13 Aprile)Tj
0 0 0 0 k
0 Tc 8 0 0 10 28.3465 489.6539 Tm
(0)Tj
0 0.9 0.85 0.3 k
-0.03 Tc 0.03 Tw 0.581 0 Td
(9.00)Tj
0 0 0 1 k
/GS2 gs
/T1_2 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.12 0 0 9.6 49.1382 489.6539 Tm
( )Tj
EMC
1.761 0 Td
(SESSIONE CLINICA EVIDENCE BASED)Tj
/T1_1 1 Tf
/Span<>> BDC
-4.041 -1.068 Td
( )Tj
EMC
0.9 0.6 0.1 0 k
/GS0 gs
/T1_3 1 Tf
4.041 0 Td
(Moderatori: )Tj
0 0 0 1 k
/GS2 gs
/T1_1 1 Tf
(R. Carassa, G. Manni, L. Mastropasqua)Tj
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 458.9001 Tm
( )Tj
EMC
3.879 0 Td
(Glaucoma a bassa pressione: miti e realt\340 - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 255.7936 458.9001 Tm
(L. Quaranta)Tj
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 448.6488 Tm
( )Tj
EMC
3.879 0 Td
(Glaucoma e riduzione della IOP - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 213.0157 448.6488 Tm
(S. Miglior)Tj
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 438.3976 Tm
( )Tj
EMC
3.879 0 Td
(Glaucoma e Neuroprotezione topica - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 234.637 438.3976 Tm
(G. Manni)Tj
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 428.1463 Tm
( )Tj
EMC
3.879 0 Td
(Glaucoma e Neuroprotezione sistemica - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 246.7874 428.1463 Tm
(L. Rossetti)Tj
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 417.895 Tm
( )Tj
EMC
3.879 0 Td
(Glaucoma e chirurgia - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 168.1282 417.895 Tm
(A. Caporossi)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.08 Tc 0.08 Tw 8 0 0 10 28.3465 397.3924 Tm
(10.35)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 1.623 Tw /Span<>> BDC
9.5 0 0 10 47.1382 397.3924 Tm
( )Tj
EMC
(Discussione)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.08 Tc 0.08 Tw 8 0 0 10 28.3465 376.8899 Tm
(10.45)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 47.1382 376.8899 Tm
( )Tj
EMC
/T1_2 1 Tf
8.544 0 0 9.6 65.1969 376.8899 Tm
(Lettura Magistrale:)Tj
/T1_0 1 Tf
8.9 0 0 10 150.1744 376.8899 Tm
( \310 possibile prevedere l\222esito della chirurgia nel )Tj
/Span<>> BDC
-13.689 -1.025 Td
( )Tj
EMC
4.141 0 Td
(Glaucoma? - )Tj
/T1_1 1 Tf
8.544 0 0 9.6 119.0946 366.6386 Tm
(L. Mastropasqua)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.08 Tc 0.08 Tw 8 0 0 10 28.3465 346.136 Tm
(11.15)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 47.1382 346.136 Tm
( )Tj
EMC
1.901 0 Td
[(Cof)17.8 (fee Break)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.08 Tc 0.08 Tw 8 0 0 10 28.3465 325.6335 Tm
(11.)Tj
(30)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 47.1382 325.6335 Tm
( )Tj
EMC
/T1_2 1 Tf
-0.02 Tc 8.544 0 0 9.6 65.1969 325.6335 Tm
(Lettura Magistrale)Tj
0 Tc 9.12 0 0 9.6 144.4841 325.6335 Tm
(: )Tj
/T1_0 1 Tf
9.5 0 0 10 150.0655 325.6335 Tm
(Danno centrale nei pazienti glaucomatosi - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 343.2745 325.6335 Tm
[(P)128.9 (. Frezzotti)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.08 Tc 0.08 Tw 8 0 0 10 28.3465 305.131 Tm
(11.50)Tj
0 0 0 1 k
/GS2 gs
/T1_2 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.12 0 0 9.6 47.1382 305.131 Tm
( )Tj
EMC
1.98 0 Td
[(QUALIT\300 DI VIT)74 (A \(QoL\))]TJ
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 284.6284 Tm
( )Tj
EMC
/T1_2 1 Tf
-0.02 Tc 8.544 0 0 9.6 65.1969 284.6284 Tm
(Lettura Magistrale)Tj
0 Tc 9.12 0 0 9.6 144.4841 284.6284 Tm
(: )Tj
/T1_0 1 Tf
9.5 0 0 10 150.0655 284.6284 Tm
(QoL all\222interno del cervello - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 278.3524 284.6284 Tm
(G. Maira)Tj
/Span<>> BDC
-27.413 -2.136 Td
( )Tj
EMC
0.9 0.6 0.1 0 k
/GS0 gs
/T1_3 1 Tf
4.041 0 Td
(Moderatori:)Tj
0 0 0 1 k
/GS2 gs
/T1_1 1 Tf
[( G. Maira, G. Manni, S. Miglior)91.8 (, A. Siracusano)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.08 Tc 0.08 Tw 8 0 0 10 28.3465 243.6233 Tm
(12.15)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 47.1382 243.6233 Tm
( )Tj
EMC
1.901 0 Td
(QoL in pazienti con patologie croniche - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 245.1915 243.6233 Tm
(C. Niolu)Tj
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 233.372 Tm
( )Tj
EMC
3.879 0 Td
(QoL e Glaucoma - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 146.4876 233.372 Tm
[(F)128.9 (. Oddone)]TJ
/T1_0 1 Tf
-0.02 Tc -0.049 Tw /Span<>> BDC
9.5 0 0 10 28.3465 223.1207 Tm
( )Tj
EMC
3.879 0 Td
[(Come )0.5 (si )0.5 (pu\362 )0.6 (migliorare )0.5 (la )0.5 (QoL )0.5 (in )0.5 (pazienti )0.5 (glaucomatosi? )0.6 (- )]TJ
/T1_1 1 Tf
9.12 0 0 9.6 308.1464 223.1207 Tm
[(R. )0.5 (Carassa, )0.5 (L. )0.6 (Rossetti,)-20 ( )]TJ
0 Tw -26.639 -1.068 Td
[(F)128.9 (.J. Goni)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 192.3669 Tm
(13.15)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1382 192.3669 Tm
( )Tj
EMC
1.69 0 Td
(Light Lunch)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 171.8643 Tm
(14.15)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1382 171.8643 Tm
( )Tj
EMC
-0.02 Tc 9.1 0 0 10 65.1969 171.8643 Tm
(Casi Clinici su QoL e Glaucoma)Tj
0 Tc 9.5 0 0 10 188.3551 171.8643 Tm
( )Tj
/Span<>> BDC
-16.843 -1.025 Td
( )Tj
EMC
0.9 0.6 0.1 0 k
/GS0 gs
/T1_3 1 Tf
9.12 0 0 9.6 65.1969 161.613 Tm
(Moderatori:)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
9.5 0 0 10 116.3777 161.613 Tm
( )Tj
/T1_1 1 Tf
9.12 0 0 9.6 119.0187 161.613 Tm
[(R. Carassa, F)128.9 (.J. Goni, C. Nucci, L. Rossetti)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
/Span<>> BDC
5.6 0 0 7 28.3465 151.3618 Tm
( )Tj
EMC
0.9 0.6 0.1 0 k
/T1_3 1 Tf
-0.01 Tc 0.01 Tw 9.12 0 0 9.6 65.1969 151.3618 Tm
(Relatori: )Tj
0 0 0 1 k
/GS2 gs
/T1_1 1 Tf
0 Tc 0 Tw 4.124 0 Td
[(L. Agnifili, M. Cesareo, M. Digiuni, T)91.8 (. Salgarello)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 130.8593 Tm
(15.00)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 1.412 Tw /Span<>> BDC
9.5 0 0 10 49.1382 130.8593 Tm
( )Tj
EMC
(Discussione)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 110.3567 Tm
(15.15)Tj
0 0 0 1 k
/GS2 gs
/T1_2 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.12 0 0 9.6 49.1382 110.3567 Tm
( )Tj
EMC
1.761 0 Td
(CONSIDERAZIONI FINALI )Tj
/T1_1 1 Tf
/Span<>> BDC
-4.041 -1.068 Td
( )Tj
EMC
0.9 0.6 0.1 0 k
/GS0 gs
/T1_3 1 Tf
4.041 0 Td
(Moderatori:)Tj
0 0 0 1 k
/GS2 gs
/T1_1 1 Tf
[( F)128.9 (.J. Goni, G. Manni, C. Nucci, L. Rossetti)]TJ
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 79.6028 Tm
( )Tj
EMC
3.879 0 Td
(Neuroprotection among EGS Therapeutical Strategies - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 310.6648 79.6028 Tm
[(F)128.9 (. T)74 (opouzis)]TJ
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 69.3516 Tm
( )Tj
EMC
3.879 0 Td
(Prospettive future sulla Neuroprotezione - )Tj
/T1_1 1 Tf
9.12 0 0 9.6 255.2424 69.3516 Tm
[(V)91.8 (. Parisi)]TJ
/T1_0 1 Tf
/Span<>> BDC
9.5 0 0 10 28.3465 59.1003 Tm
( )Tj
EMC
3.879 0 Td
[(T)74 (ake Home Message - )]TJ
/T1_1 1 Tf
9.12 0 0 9.6 163.7493 59.1003 Tm
(R. Carassa)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 38.5977 Tm
(16.00)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1382 38.5977 Tm
( )Tj
EMC
/T1_4 1 Tf
1.69 0 Td
(Conclusioni )Tj
0 0.9 0.85 0.3 k
/GS0 gs
/TT0 1 Tf
-0.03 Tc 0.03 Tw 8 0 0 10 28.3465 28.3464 Tm
(16.15)Tj
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0 Tc 0 Tw /Span<>> BDC
9.5 0 0 10 49.1382 28.3464 Tm
( )Tj
EMC
/T1_4 1 Tf
1.69 0 Td
(Questionario ECM)Tj
ET
q
0 0 850.394 850.394 re
W n
0.27 0.18 0.03 0 k
/GS0 gs
q 1 0 0 1 459.5433 805.0394 cm
0 0 m
-6 0 -6 -6 v
-6 -8.173 l
-6 -14.173 0 -14.173 v
356.504 -14.173 l
362.504 -14.173 362.504 -8.173 v
362.504 -6 l
362.504 0 356.504 0 v
h
f
Q
Q
BT
/TT0 1 Tf
-0.03 Tc 9.6 0 0 12 585.4927 793.3749 Tm
(Relatori e Moderatori)Tj
ET
q
0 0 850.394 850.394 re
W n
0.27 0.18 0.03 0 k
/GS0 gs
q 1 0 0 1 459.5433 174.3307 cm
0 0 m
-6 0 -6 -6 v
-6 -8.173 l
-6 -14.173 0 -14.173 v
357.921 -14.173 l
363.921 -14.173 363.921 -8.173 v
363.921 -6 l
363.921 0 357.921 0 v
h
f
Q
Q
BT
9.6 0 0 12 578.3945 162.6662 Tm
(INFORMAZIONI GENERALI)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
0 Tc 9.5 0 0 10 453.5433 771.7476 Tm
(Luca Agni\037li)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
-0.02 Tc 9.12 0 0 9.6 453.5433 758.7476 Tm
[(Centro Regionale dei Glaucomi, Universit\340)-20 ( )]TJ
0 -1.354 Td
(degli Studi \223G. d\222Annunzio\224, Chieti-Pescara)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
0 Tc 9.5 0 0 10 453.5433 728.4956 Tm
(Stefania Bianchi Marzoli)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 715.4956 Tm
(Fondazione IRCCS Istituto Auxologico )Tj
0 -1.354 Td
(Italiano, Milano)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 685.2437 Tm
(Rupert Bourne)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 672.2437 Tm
[(Anglia Ruskin University)74 (, Cambridge \(UK\))]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 654.9917 Tm
(Aldo Caporossi)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 641.9917 Tm
(Fondazione Policlinico Universitario )Tj
9.12 0 0 9.6 607.5967 641.9917 Tm
( )Tj
9.12 0 0 9.6 453.5433 628.9917 Tm
(A. Gemelli, Roma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 611.7397 Tm
(Roberto Carassa)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 598.7397 Tm
(Centro Italiano Glaucoma, Milano)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 581.4877 Tm
(Massimo Cesareo )Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 568.4877 Tm
[(Universit\340 T)73.9 (or V)36.9 (ergata, Roma)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 551.2358 Tm
(David Crabb)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 538.2358 Tm
[(City University)73.9 (, London \(UK\))]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 520.9838 Tm
(Maurizio Digiuni)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 507.9838 Tm
(Ospedale San Paolo, Milano)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 490.7318 Tm
(Michele Figus)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
-0.01 Tc 9.12 0 0 9.6 453.5433 477.7318 Tm
[(Azienda Ospedaliero-Universitaria Pisana,)-10 ( )]TJ
0.01 Tw 0 -1.354 Td
(Pisa)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
0 Tc 0 Tw 9.5 0 0 10 453.5433 447.4799 Tm
(Paolo Frezzotti)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 434.4799 Tm
(Policlinico S. Maria Le Scotte, Siena)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 417.2279 Tm
(Stefano Gandol\037)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 404.2279 Tm
(Universit\340 di Parma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 386.9759 Tm
[(David F)128.9 (. Garway-Heath)]TJ
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 373.9759 Tm
(Moorfields Eye Hospital, London \(UK\))Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 356.724 Tm
(Francisco Javier Goni)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 343.724 Tm
[(CTIG - T)74 (eknon, Barcelona \(ES\))]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 326.472 Tm
(Michele Iester)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 313.472 Tm
(Universit\340 degli Studi di Genova)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 296.22 Tm
(Alessandro Lambiase)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 283.22 Tm
(Sapienza Universit\340 di Roma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 265.9681 Tm
(Giulio Maira)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 252.9681 Tm
(Istituto Clinico Humanitas, Milano)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 453.5433 235.7161 Tm
(Gianluca Manni)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 453.5433 222.7161 Tm
[(Universit\340 T)73.9 (or V)36.9 (ergata, Roma)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 771.7476 Tm
(Leonardo Mastropasqua)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 758.7476 Tm
(Universit\340 degli Studi \223G. d\222Annunzio\224, )Tj
0 -1.354 Td
(Chieti-Pescara)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 728.4956 Tm
(Michela Matteoli)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 715.4956 Tm
(Istituto Clinico Humanitas, Milano)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 698.2437 Tm
(Manuele Michelessi)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 685.2437 Tm
(Fondazione G.B. Bietti, Roma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 667.9917 Tm
(Stefano Miglior)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 654.9917 Tm
(Universit\340 degli Studi di Milano-Bicocca)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 637.7397 Tm
(Cinzia Niolu)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 624.7397 Tm
[(Universit\340 T)73.9 (or V)36.8 (ergata, Roma)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 607.4877 Tm
(Carlo Nucci )Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 594.4877 Tm
[(Universit\340 T)73.9 (or V)36.8 (ergata, Roma)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 577.2358 Tm
(Francesco Oddone)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 564.2358 Tm
(Fondazione G.B. Bietti, Roma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 546.9838 Tm
[(V)17.8 (incenzo Parisi)]TJ
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 533.9838 Tm
(Fondazione G.B. Bietti, Roma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 516.7318 Tm
(Andrea Perdicchi)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 503.7318 Tm
(Azienda Ospedaliera Sant\222Andrea, Roma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 486.4799 Tm
(Luciano Quaranta)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 473.4799 Tm
(Universit\340 degli Studi di Brescia )Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 456.2279 Tm
(Luca Rossetti)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 443.2279 Tm
(Polo Universitario San Paolo, Milano)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 425.9759 Tm
(Matteo Sacchi)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 412.9759 Tm
(Ospedale San Giuseppe Milano, )Tj
0 -1.354 Td
(Universit\340 degli Studi di Milano)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 382.724 Tm
[(T)74 (ommaso Salgarello)]TJ
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 369.724 Tm
(Fondazione Policlinico Universitario )Tj
9.12 0 0 9.6 798.9352 369.724 Tm
( )Tj
9.12 0 0 9.6 644.8819 356.724 Tm
(A. Gemelli, Roma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 339.472 Tm
(Gianluca Scuderi)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 326.472 Tm
(Azienda Ospedaliera Sant\222Andrea, Roma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 309.22 Tm
(Alberto Siracusano )Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 296.22 Tm
[(Universit\340 T)73.9 (or V)36.8 (ergata, Roma)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 278.968 Tm
(Mario Stirpe)Tj
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 265.9681 Tm
(Fondazione G.B. Bietti, Roma)Tj
0 0.9 0.85 0.3 k
/GS0 gs
/T1_0 1 Tf
9.5 0 0 10 644.8819 248.7161 Tm
[(Fotis T)74 (opouzis)]TJ
0 0 0 1 k
/GS2 gs
/T1_4 1 Tf
9.12 0 0 9.6 644.8819 235.7161 Tm
(Aristotle University of Thessaloniki \(GR\))Tj
/T1_3 1 Tf
9.5 0 0 10 463.5649 135.2284 Tm
[(L)74 (\222italiano \350 la lingua uf\037ciale del Congr)17.8 (esso. Per le r)17.8 (elazioni in lingua inglese \350 )]TJ
10.347 -1.2 Td
[(pr)17.8 (evista la traduzione simultanea.)]TJ
0 0.9 0.85 0.3 k
/GS0 gs
-4.479 -2.4 Td
(CREDITI EDUCAZIONE CONTINUA IN MEDICINA \(ECM\))Tj
ET
q
132.661431 0 0 17.5950943 571.4646606 77.9898056 cm
/Im0 Do
Q
BT
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
0.128 Tw 9.5 0 0 10 453.5434 64.3465 Tm
(Sono stati assegnati )Tj
/T1_3 1 Tf
[(n. 6,3 cr)17.9 (editi ECM)]TJ
/T1_0 1 Tf
[(. L)91.8 (\222evento \350 stato accreditato per la \037gura )]TJ
0 Tw 0 -1.2 Td
(professionale del )Tj
/T1_3 1 Tf
(medico chirurgo specialista in oftalmologia)Tj
/T1_0 1 Tf
(.)Tj
/T1_4 1 Tf
0 -1.2 Td
(Per ricevere i crediti formativi \350 necessario partecipare ad entrambe\
le giornate per )Tj
0 -1.2 Td
(il 100% delle ore formative.)Tj
ET
0.9 0.6 0.1 0 K
0.5 w 4 M
/GS0 gs
q 1 0 0 1 56.9429 786.6142 cm
0 0 m
0 -758.268 l
S
Q
endstream
endobj
23 0 obj
<>
endobj
27 0 obj
<>/ProcSet[/PDF/ImageC]/XObject<>>>/Subtype/Form>>stream
q
/GS0 gs
1099.8425667 0 0 824.881925 -124.7244186 -9.9213537 cm
/Im0 Do
Q
endstream
endobj
28 0 obj
<>stream
Adobe d
!"124AQSbr
#$%&'()*356789:BCDEFGHIJRTUVWXYZacdefghijqstuvwxyz !1"AQa4BRqr
#$%&'()*2356789:CDEFGHIJSTUVWXYZbcdefghijstuvwxyz ? `
.-9:A>]䥪kZz$I8ac](H 1fPH4KfH5Uab M/^eT]UX9ђe"SR4+R
}FnG IcM@,SӱӤXđQaE2:4-`Σꓐ(Cd
ZeUpoGaE*,hReʚ)}$kͽYnUVJJIUؐ "OTsRPČ#H͒ԙND&65K"TT7(-(PX*V,*U]`-Eq*CLWړ#2.L!zU6dc/f(+3pHVD )TBબk25KA|CYYA±$^hꬸhU`vFdΒZbC;Yf+! 2Rk
sI) e
$'@΄#6Q|2hX=Y=dHKu*S``P8ma,xACUA0U5UUqZ_܃Qrn!TIT!p)"HSXbыB AA#EVB*&e"NTIuE#HPn1Ҍ@-2amUR!2;L.!^ ,1nT+B)DOEiOJ8\ZEE+
,k&e%H ,&2H('&"#%0# (RSE0
UhjAr*81vUL"؇9HX~
SP(2XD]Pˬ@K¨ʒgRwp[˸~WJ-xc=K,@F1RU_J4X:@F*w]VEi蒪ϠykZz$%EjV* wZDR]339RR